Related Experiment Video
Updated: Mar 29, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study
Matsuhiko Hayashi1, Takayuki Abe2,3, Mieko Iwai4
1Apheresis and Dialysis Center, Keio University School of Medicine, Keio University, 35 Shinanomachi, Shinjuku-ku, 160-8582, Tokyo, Japan. matuhiko@keio.jp.
Insights
Warfarin therapy in Japanese hemodialysis patients appears safe for chronic use, with no increased risk of death or composite events. However, safety during therapy initiation requires further investigation.
Area of Science:
- Nephrology
- Cardiology
- Pharmacology
Background:
- Assessing the safety of warfarin therapy in Japanese hemodialysis (HD) patients.
- Warfarin is a common anticoagulant, but its use in HD patients requires careful consideration due to potential bleeding risks.
Purpose of the Study:
- To evaluate the safety and efficacy of warfarin in Japanese patients undergoing chronic hemodialysis.
- To determine if warfarin use is associated with increased mortality or adverse cardiovascular events in this population.
Main Methods:
- A multicenter prospective cohort study involving 365 warfarin users and 692 non-users from 111 HD centers in Japan.
- Patients were followed for up to 36 months, with clinical data collected at baseline and annually.
- Multivariate Cox proportional-hazard models were used to analyze the association between warfarin use, age, and clinical outcomes.
Main Results:
- Warfarin use was not significantly associated with an increased risk of death from any cause (HR 1.08, p=0.68) after adjusting for covariates.
- Age was a significant predictor of mortality (HR 1.07 per year increase, p<0.001).
- The risk of composite events (death, stroke, cardiovascular disease, peripheral arterial disease) was also not associated with warfarin use.
Conclusions:
- Warfarin therapy may be safe for Japanese hemodialysis patients in the chronic state.
- Further research is needed to determine the safety of initiating warfarin therapy in this patient group.
Background:
We conducted a multicenter prospective cohort study to assess the safety of warfarin therapy in Japanese hemodialysis (HD) patients.
Methods:
Chronic HD patients on warfarin therapy (warfarin users) were recruited from 111 HD centers in Japan. Two dialysis-vintage-matched warfarin non-users (non-users) were selected from the same HD center as each warfarin user. Clinical data were collected upon registration and every 12 months thereafter for up to 36 months.
Results:
The final cohort consisted of 365 warfarin users and 692 non-users and was followed for an average of 27.7 months. The mean age of warfarin users (68.8 ± 10.6 years) was significantly higher than that of non-users (66.9 ± 11.0 years, p < 0.001). The analyses by multivariate Cox proportional-hazard models showed that the age [hazard ratio (HR) = 1.07 for each 1-year increase, 95 % confidence interval (CI) 1.05-1.08, p < 0.001] was significantly associated with the death from any cause, but warfarin use (1.08, CI 0.75-1.57, p = 0.68) was not when being adjusted for sex, diabetes mellitus, antiplatelet use, and atrial fibrillation. The risk of composite events, which included death from any cause, stroke, cardiovascular disease, and peripheral arterial disease, was also associated with age but was not associated with warfarin use.
Conclusion:
The results of this study suggested that warfarin use by HD patients might not be harmful in chronic state, while the safety for the initiation of warfarin therapy in HD patients remained to be determined.
Related Concept Videos
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Hemodialysis II: Procedure and Complications
Venous Thrombosis III: Interprofessional Care
Chronic Kidney Disease III: Interprofessional Care
Hemodialysis III: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

